The 4th edition of Investing in Life Science takes place on September 22 in Stockholm. Stian Kildal, CEO will present OncoZenge to specialist life science investors and potential strategic partners.
Investing in Life Science serves as a dedicated platform connecting innovation with capital, offering Nordic life science companies the opportunity to pitch to both Swedish and international high-level investors in an exclusive boutique setting.
Event Details:
Spaces are limited, register today to secure your attendance.
The presentations will be filmed and made available in the days following the event on BioStock’s website and LinkedIn.